Relationship between non-alcoholic fatty liver disease and benign prostatic hyperplasia/lower urinary tract symptoms: new insights from an Italian cross-sectional study-Reference-Cited by-同舟云学术

Relationship between non-alcoholic fatty liver disease and benign prostatic hyperplasia/lower urinary tract symptoms: new insights from an Italian cross-sectional study

Published:2014-09-05 Issue:5 Volume:33 Page:743-751
ISSN:0724-4983
Container-title:World Journal of Urology
language:en
Short-container-title:World J Urol

Author:

Russo Giorgio Ivan,Cimino Sebastiano,Fragalà Eugenia,Privitera Salvatore,La Vignera Sandro,Condorelli Rosita,Calogero Aldo E.,Chisari Mario,Castelli Tommaso,Favilla Vincenzo,Morgia Giuseppe

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

http://link.springer.com/content/pdf/10.1007/s00345-014-1392-4.pdf

Reference30 articles.

1. Gacci M, Eardley I, Giuliano F, Hatzichristou D, Kaplan SA, Maggi M, McVary KT, Mirone V, Porst H, Roehrborn CG (2011) Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia. Eur Urol 60(4):809–825. doi: 10.1016/j.eururo.2011.06.037

2. Lee JH, Kwon H, Park YW (2013) Association of lower urinary tract symptom/benign prostatic hyperplasia measures with international index of erectile function 5 in middle-aged policemen of Korea and the role of metabolic syndrome and testosterone in their relationship. Urology 82(5):1008–1012. doi: 10.1016/j.urology.2013.07.003

3. Smits MM, Ioannou GN, Boyko EJ, Utzschneider KM (2013) Non-alcoholic fatty liver disease as an independent manifestation of the metabolic syndrome: results of a US national survey in three ethnic groups. J Gastroenterol Hepatol 28(4):664–670. doi: 10.1111/jgh.12106

4. Watanabe S, Yaginuma R, Ikejima K, Miyazaki A (2008) Liver diseases and metabolic syndrome. J Gastroenterol 43(7):509–518. doi: 10.1007/s00535-008-2193-6

5. Rafiq N, Younossi ZM (2009) Nonalcoholic fatty liver disease: a practical approach to evaluation and management. Clin Liver Dis 13(2):249–266. doi: 10.1016/j.cld.2009.02.009

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of Palmitoylethanolamide, Epilobium and Calendula suppositories for the treatment of patients with chronic prostatitis/chronic pelvic pain syndrome type III;Archivio Italiano di Urologia e Andrologia;2024-06-27

2. Association between nonalcoholic fatty liver disease and erectile dysfunction among American Adults from the National Health and Nutrition Examination Survey: a cross-sectional study;International Journal of Impotence Research;2024-05-23

3. Association between nonalcoholic fatty liver disease and erectile dysfunction among American Adults from the National Health and Nutrition Examination Survey: A cross-sectional study;2023-10-27

4. Fatty liver index (FLI): more than a marker of hepatic steatosis;Journal of Physiology and Biochemistry;2023-10-25

5. Is There a Link Between Non-Alcoholic Fatty Liver Disease and Benign Prostate Hyperplasia/Lower Urinary Tract Symptoms: A Systematic Review and a Meta-Analysis;Metabolic Syndrome and Related Disorders;2023-09-01